| A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization MC Morice, PW Serruys, JE Sousa, J Fajadet, E Ban Hayashi, M Perin, ... New England Journal of Medicine 346 (23), 1773-1780, 2002 | 5758 | 2002 |
| Strategies for multivessel revascularization in patients with diabetes ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, ... New England journal of medicine 367 (25), 2375-2384, 2012 | 2202 | 2012 |
| Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease PW Serruys, F Unger, JE Sousa, A Jatene, HJRM Bonnier, ... New England Journal of Medicine 344 (15), 1117-1124, 2001 | 1666 | 2001 |
| Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional … JE Sousa, MA Costa, A Abizaid, AS Abizaid, F Feres, IMF Pinto, ... Circulation 103 (2), 192-195, 2001 | 1307 | 2001 |
| Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up JE Sousa, MA Costa, AC Abizaid, BJ Rensing, AS Abizaid, LF Tanajura, ... Circulation 104 (17), 2007-2011, 2001 | 1076 | 2001 |
| Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I GW Stone, DE Kandzari, R Mehran, A Colombo, RS Schwartz, S Bailey, ... Circulation 112 (15), 2364-2372, 2005 | 943 | 2005 |
| Polymer-free drug-coated coronary stents in patients at high bleeding risk P Urban, IT Meredith, A Abizaid, SJ Pocock, D Carrié, C Naber, J Lipiecki, ... New England Journal of Medicine 373 (21), 2038-2047, 2015 | 865 | 2015 |
| Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial F Feres, RA Costa, A Abizaid, MB Leon, JA Marin-Neto, RV Botelho, ... Jama 310 (23), 2510-2522, 2013 | 776 | 2013 |
| Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy … P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ... The Lancet 392 (10151), 940-949, 2018 | 740 | 2018 |
| The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation A Abizaid, R Kornowski, GS Mintz, MK Hong, AS Abizaid, R Mehran, ... Journal of the American College of Cardiology 32 (3), 584-589, 1998 | 718 | 1998 |
| Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the … PW Serruys, M Degertekin, K Tanabe, A Abizaid, JE Sousa, A Colombo, ... Circulation 106 (7), 798-803, 2002 | 584 | 2002 |
| Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial RTD Oliver, MD Mason, GM Mead, H von der Maase, GJS Rustin, JK Joffe, ... The Lancet 366 (9482), 293-300, 2005 | 525 | 2005 |
| American heart association council on E, prevention statistics c, stroke statistics s. heart disease and stroke statistics-2019 update: a report from the American heart association EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ... Circulation 139 (10), e56-e528, 2019 | 518 | 2019 |
| Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization … A Abizaid, MA Costa, M Centemero, AS Abizaid, VMG Legrand, RV Limet, ... Circulation 104 (5), 533-538, 2001 | 509 | 2001 |
| Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries JE Sousa, MA Costa, AGMR Sousa, AC Abizaid, AC Seixas, AS Abizaid, ... Circulation 107 (3), 381-383, 2003 | 495 | 2003 |
| Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry P Urban, AH Gershlick, G Guagliumi, P Guyon, C Lotan, J Schofer, A Seth, ... Circulation 113 (11), 1434-1441, 2006 | 456 | 2006 |
| Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of … T Palmerini, U Benedetto, L Bacchi-Reggiani, D Della Riva, ... The Lancet 385 (9985), 2371-2382, 2015 | 433 | 2015 |
| Efficacy and safety of dual antiplatelet therapy after complex PCI G Giustino, A Chieffo, T Palmerini, M Valgimigli, F Feres, A Abizaid, ... Journal of the American College of Cardiology 68 (17), 1851-1864, 2016 | 407 | 2016 |
| Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves D Dvir, T Bourguignon, CM Otto, RT Hahn, R Rosenhek, JG Webb, ... Circulation 137 (4), 388-399, 2018 | 392 | 2018 |
| Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a … M Haude, H Ince, A Abizaid, R Toelg, PA Lemos, C Von Birgelen, ... The Lancet 387 (10013), 31-39, 2016 | 386 | 2016 |
